Press release
Alzheimer's Drugs Market Size Worth $9.8 Billion by 2027 | CAGR 6.21%
Alzheimer's disease (AD) is a chronic or persistent disorder that attacks the brain cells, affecting memory, thinking and behavior. Alzheimer's drugs refer to medications that help lessen symptoms, such as memory loss and confusion, for a limited time. These drugs also influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.
Covid-19 Scenario:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download a free sample report to get a detailed overview of the report: https://www.imarcgroup.com/alzeimers-drugs-market/requestsample
Alzheimer's Drugs Market Trends:
The global Alzheimer's drugs market is primarily driven by the increasing number of people diagnosed with Alzheimer's disease. Besides this, the increasing prevalence of chronic diseases, such as diabetes, obesity, heart diseases and high blood pressure (BP), that increase the risk of Alzheimer's are contributing to the market. This is further supported by unhealthy dietary patterns, sedentary lifestyles and smoking, which are known to increase the chances of developing Alzheimer's disease. Moreover, several pharmaceutical companies are developing drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The development of these drugs is anticipated to propel market growth in the coming years.
Global Alzheimer's Drugs Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
AbbVie (NYSE: ABBV), AstraZeneca PLC (AZN), Biogen Inc. (BIIB)., Daiichi Sankyo Company, Limited (DSNKY), Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/alzeimers-drugs-market
The report has segmented the market on the basis of Type, Thickness, Production Process, Application and Region.
By Drug Class:
Donepezil
Galantamine
Rivastigmine
Memantine
Others
By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Stores
Others
By Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Contact Us
30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Drugs Market Size Worth $9.8 Billion by 2027 | CAGR 6.21% here
News-ID: 2811146 • Views: …
More Releases from IMARC Group
Meat Processing Plant Setup: Key Insights for a Successful Industrial Venture
Setting up a meat processing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Meat Processing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a meat processing plant, covering everything from product overview and processing processes to…
Sanitary Napkin Manufacturing Unit Setup: Business Model & Cost Feasibility
Setting up a sanitary napkin manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Sanitary Napkin Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a sanitary napkin manufacturing plant, covering everything from product overview and…
Drone Photography/Videography Project Report 2025: Market Trends and Business Op …
Drone Photography/Videography Business Plan & Project Report Overview
IMARC Group's "Drone Photography/Videography Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful drone photography/videography business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining an existing one,…
Sustainable Fashion Consulting Business Plan 2025: Costs, Setup, and Profit Pote …
Sustainable Fashion Consulting Business Plan & Project Report Overview
IMARC Group's "Sustainable Fashion Consulting Business Plan and Project Report 2025" offers a comprehensive framework for establishing a successful sustainable fashion consulting business. The critical areas, including market trends, investment opportunities, revenue models, and financial forecasts, are discussed in this in-depth report and are therefore useful resources to entrepreneurs, consultants and investors. Whether evaluating the viability of a new venture or streamlining…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
